Hemostemix Inc.
TSX VENTURE : HEM

Hemostemix Inc.

January 12, 2015 09:26 ET

Hemostemix Inc.: Corporate Update

CALGARY, ALBERTA--(Marketwired - Jan. 12, 2015) - Hemostemix Inc. (the "Corporation") (TSX VENTURE:HEM) announces Dr. Valentin Fulga, is leaving the company's management team where he was President, effective immediately. Dr. Fulga will continue to serve as a director.

About Hemostemix

Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments. Hemostemix Inc. is traded on the TSX Venture Exchange under the trading symbol "HEM".

Neither the TSX Venture Exchange, Inc. nor its Regulation Service Provider (as that term is defined under the policies of the TSX Venture Exchange) has in any way passed upon the merits of this news release and has neither approved nor disapproved of the contents of this press release.

Contact Information

  • Hemostemix Inc.
    Dr. Elmar Burchardt
    CEO
    (617) 500-8401

    Hemostemix Inc.
    C.W. (Bill) Baker
    Chairman of the Board
    (403) 818-7672